Kazuko Machida

513 total citations
53 papers, 353 citations indexed

About

Kazuko Machida is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Kazuko Machida has authored 53 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 23 papers in Pulmonary and Respiratory Medicine and 21 papers in Surgery. Recurrent topics in Kazuko Machida's work include Tuberculosis Research and Epidemiology (21 papers), Diagnosis and treatment of tuberculosis (14 papers) and Mycobacterium research and diagnosis (10 papers). Kazuko Machida is often cited by papers focused on Tuberculosis Research and Epidemiology (21 papers), Diagnosis and treatment of tuberculosis (14 papers) and Mycobacterium research and diagnosis (10 papers). Kazuko Machida collaborates with scholars based in Japan, Netherlands and China. Kazuko Machida's co-authors include Naohiro Nagayama, Hideki Yotsumoto, Yoshiko Kawabe, Atsuyuki Kurashima, Atsuhisa Tamura, Takuo Aoyagi, Katsuyuki Miyasaka, Naoki Kobayashi, Hideaki Nagai and Akira Hebisawa and has published in prestigious journals such as Anesthesia & Analgesia, Journal of the Neurological Sciences and Muscle & Nerve.

In The Last Decade

Kazuko Machida

51 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuko Machida Japan 11 112 109 107 101 45 53 353
Samuel Weinstein United States 13 87 0.8× 57 0.5× 79 0.7× 223 2.2× 16 0.4× 21 570
Markus Busch Germany 9 89 0.8× 140 1.3× 91 0.9× 99 1.0× 11 0.2× 19 402
Tuğrul Şipit Türkiye 11 133 1.2× 136 1.2× 153 1.4× 100 1.0× 56 1.2× 20 423
Enes Elvin Gül Türkiye 15 88 0.8× 68 0.6× 56 0.5× 88 0.9× 29 0.6× 87 617
Bryan Wai United States 16 44 0.4× 115 1.1× 78 0.7× 100 1.0× 20 0.4× 26 675
Silvia Magnani Italy 15 135 1.2× 159 1.5× 33 0.3× 52 0.5× 115 2.6× 36 951
Francisco Alvarez United States 12 275 2.5× 29 0.3× 73 0.7× 136 1.3× 43 1.0× 36 456
Rushi V. Parikh United States 11 81 0.7× 52 0.5× 60 0.6× 138 1.4× 64 1.4× 52 417
Shi-Chuan Chang Taiwan 12 164 1.5× 33 0.3× 63 0.6× 93 0.9× 36 0.8× 30 338
Hafez Mohammad Ammar Abdullah United States 11 95 0.8× 28 0.3× 46 0.4× 126 1.2× 17 0.4× 71 364

Countries citing papers authored by Kazuko Machida

Since Specialization
Citations

This map shows the geographic impact of Kazuko Machida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuko Machida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuko Machida more than expected).

Fields of papers citing papers by Kazuko Machida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuko Machida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuko Machida. The network helps show where Kazuko Machida may publish in the future.

Co-authorship network of co-authors of Kazuko Machida

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuko Machida. A scholar is included among the top collaborators of Kazuko Machida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuko Machida. Kazuko Machida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuboi, Tomomasa, Toru Oga, Kensuke Sumi, et al.. (2014). The Importance of Controlling P aCO 2 Throughout Long-Term Noninvasive Ventilation. Respiratory Care. 59(11). 1671–1678. 8 indexed citations
2.
Machida, Kazuko, Ayako Tsuchiya‐Suzuki, Kenji Sano, et al.. (2012). Postmortem findings in a patient with cerebral amyloid angiopathy actively treated with corticosteroid. Amyloid. 19(1). 47–52. 9 indexed citations
3.
Tsuboi, Tomomasa, Toru Oga, Kazuko Machida, et al.. (2011). PaCO2 Six months after the Initiation of Long-term Noninvasive Ventilation in Patients with COPD. Internal Medicine. 50(6). 563–570. 7 indexed citations
4.
Tsuboi, Tomomasa, Motoharu Ohi, Toru Oga, et al.. (2010). Importance of the PaCO2 from 3 to 6 months after initiation of long-term non-invasive ventilation. Respiratory Medicine. 104(12). 1850–1857. 8 indexed citations
5.
Tsuboi, Tomomasa, Toru Oga, Kazuko Machida, et al.. (2009). Importance of ventilator mode in long-term noninvasive positive pressure ventilation. Respiratory Medicine. 103(12). 1854–1861. 14 indexed citations
6.
Nagayama, Naohiro, Yoshiko Kawabe, Junichi Suzuki, et al.. (2008). [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].. PubMed. 83(1). 13–9. 16 indexed citations
7.
Tojo, Kana, Yoshiki Sekijima, Kazuko Machida, et al.. (2008). Amyloidogenic transthyretin Val30Met homozygote showing unusually early‐onset familial amyloid polyneuropathy. Muscle & Nerve. 37(6). 796–803. 12 indexed citations
9.
Matsui, Yoshinori, Shinobu Akagawa, Masahiro Kawashima, et al.. (2007). [Examination of administrative dosage of cyclosporine during anti-tuberculosis chemotherapy including rifampicin].. PubMed. 82(7). 563–7. 1 indexed citations
10.
Aoyagi, Takuo, et al.. (2007). Multiwavelength Pulse Oximetry: Theory for the Future. Anesthesia & Analgesia. 105(6). S53–S58. 47 indexed citations
11.
Machida, Kazuko & Ryoji Maekura. (2005). [State of the art: sequelae of tuberculosis].. PubMed. 80(10). 655–74. 5 indexed citations
12.
Tamura, Atsuhisa, Akira Hebisawa, Junko Suzuki, et al.. (2005). [Coexistence of lung cancer and active pulmonary mycobacteriosis].. PubMed. 80(5). 413–9. 7 indexed citations
13.
Hara, Hiromichi, Hideaki Nagai, Atsuhisa Tamura, et al.. (2004). [A case of pulmonary aspergillosis with bone invasion and destruction in an AIDS patient].. PubMed. 42(9). 854–8. 2 indexed citations
14.
Tamura, Atsuhisa, Akira Hebisawa, Junko Suzuki, et al.. (2004). [Pulmonary nontuberculous mycobacteriosis in patients with lung cancer].. PubMed. 79(6). 367–73. 10 indexed citations
15.
Nagayama, Naohiro, Yuichiro Shishido, Kimihiko Masuda, et al.. (2004). [Leukopenia due to anti-tuberculous chemotherapy including rifampicin and isoniazid].. PubMed. 79(5). 341–8. 17 indexed citations
16.
Kawabe, Yoshiko, Shigeru Tanaka, Hideaki Nagai, et al.. (2004). [Evaluation of quantitative fit-testing of N95 filtering facepiece respirators using Mask-Fitting Tester and improvement of mask fitting by instruction].. PubMed. 79(7). 443–8. 3 indexed citations
17.
Nagayama, Naohiro, Kimihiko Masuda, Atsuhisa Tamura, et al.. (2003). [Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin].. PubMed. 78(4). 339–46. 2 indexed citations
18.
Tamura, Atsuhisa, Akira Hebisawa, Kôji Hayashi, et al.. (1999). Lung Cancer in Patients Who Had Received Thoracoplasty for Pulmonary Tuberculosis. Japanese Journal of Clinical Oncology. 29(11). 541–545. 15 indexed citations
19.
Tamura, Atsuhisa, Akira Hebisawa, Gaku TANAKA, et al.. (1999). [Active pulmonary tuberculosis in patients with lung cancer].. PubMed. 74(11). 797–802. 15 indexed citations
20.
Hayashi, Kôji, et al.. (1998). Lung Cancer in Patients with Pulmonary Emphysema.. Haigan. 38(4). 317–321. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026